Clarivate

APRIL 24, 2023

healthcare payers and providers are consolidating at a dizzying clip as they seek to gain market share, increase access to care and secure clinical control to improve health outcomes. Payers are responding by creating, acquiring or fortifying provider networks and healthcare clinics of their own.

Healthcare 89

Healthcare Healthcare Marketing Physicians 89

Clarivate

JANUARY 23, 2024

To learn more about how Clarivate and CMR International help pharmas future-proof their portfolios, please visit us here. She has extensive experience working with the business intelligence teams of leading pharmaceutical companies on topics such as R&D productivity , portfolio risk and protocol complexity.

Pharma 52

Pharma Sales Consulting Pharmaceutical 52

Clarivate

JULY 31, 2023

Following the acquisition of Dialog Solutions as part of the ProQuest M&A in December 2021, Dialog Solutions products and services will be folded into the Clarivate portfolio of offerings for Life Sciences & Healthcare. To learn more about the Dialog platform, visit: here.

Healthcare 52

Healthcare Healthcare Safety Competition 52

Impetus Digital

MARCH 15, 2024

Emerging biopharma companies are responsible for over 70% of these products (up 20 percentage points from 2017) while Big Pharma has seen a declining share of the oncology pipeline, at only around 20% of products currently under development (down 15 percentage points from 2017).

Recruitment 78

Recruitment Healthcare Provider Patients Healthcare 78

pharmaphorum

AUGUST 4, 2022

This is due to the specialist nature of roles and the growth and diversification of biopharma, which requires an increasingly sophisticated and skilled workforce. Furthermore, by simulating real-life scenarios, AR offers the chance for staff in the pharma industry to practice complex operations without the associated risks.

Recruitment 98

Recruitment Pharma Training Pharmaceutical manufacturing 98

PM360

MAY 2, 2023

Ardelis Health , a healthcare strategic marketing agency and consulting firm partnering with innovators that discover, differentiate, and launch important therapies, today announced the appointment of industry veteran Timmy Garde as Chief Growth Officer. “We I’m excited to join Ardelis and lead the next phase of our growth,” said Garde.

Food and Drug Administration 52

Food and Drug Administration Healthcare Healthcare Biopharma 52

PM360

APRIL 22, 2024

In this issue, we take a closer look on the importance of patient education to Healthcare Professionals and navigating the challenges that arise. With an ever- increasing demand for their time and attention, it is more difficult than ever for biopharma representatives to convey their message to the physician audience.

Education 59

Education Physicians Healthcare Healthcare 59

Pharma Marketing Network

SEPTEMBER 15, 2021

15 September, 2021)—With gender inequality a continued area of focus for corporations and workplaces around the globe, the Healthcare Businesswomen’s Association (HBA) is proud to recognize Merck & Co., for exemplary workplace initiatives working to close the gender gap in the healthcare and life science industries.

Healthcare 52

Healthcare Healthcare Networking Management 52

pharmaphorum

DECEMBER 23, 2022

In 2022, life sciences companies have been hard at work breaking down silos to better serve patients and healthcare professionals (HCPs). With these silos breaking down, biopharmas will have the opportunity to drive a more coordinated approach to HCP engagement using shared data and unified systems, while still maintaining compliance.

Marketing 104

Marketing Sales Medical Patients 104

PM360

DECEMBER 14, 2023

Moderna Joins CEPI Pandemic Preparedness Mission After making its debut in the pharma market during the COVID-19 pandemic, Moderna is preparing for the next pandemic. The pharma company has joined the Coalition for Epidemic Preparedness Innovations (CEPI) in a partnership that aims to shorten vaccine development timelines down to 100 days.

Physicians 52

Physicians Pharma Medical Patients 52

pharmaphorum

OCTOBER 20, 2022

In my experience working on global biopharma brands, commercial success is built on collaboration and solid basics. After years of navigating non-scalable pharma processes, I founded PurpleLeaf Strategy to introduce our take on a solution: Enavia , a commercial excellence suite that’s built in the cloud.

Competition 98

Competition Marketing Pharma Biopharma 98

PM360

AUGUST 24, 2023

PM360 , a leading life sciences marketing industry trade publication, established the Trailblazer Awards in 2009 to recognize and honor outstanding companies, marketers, marketing teams, brand managers, and initiatives that have demonstrated innovation and achieved incredible results in the life sciences.

Marketing 52

Marketing Education Media Healthcare 52

PM360

OCTOBER 3, 2023

PRODUCT LAUNCH OF THE YEAR NEXTSTELLIS (Mayne Pharma and EVERSANA INTOUCH) RELAUNCH/REVITALIZATION OF THE YEAR VRAYLAR (AbbVie Inc. Diversity/Multicultural: Anna Czene, Vice President, Corporate Communications & DEI Lead, CareDx, Inc. and Publicis NY) BRAND CHAMPION AWARD WINNERS Autoimmune/Rheumatology: Katrina Sergeev Gary, Sr.

Education 122

Education Marketing Media Management 122

Clarivate

MAY 14, 2024

While initially developed to help regulate blood sugar levels, they have also been found to promote appetite suppression, leading to weight loss in patients. What’s leading to the boom in development of semaglutide biosimilars? Contact us to learn more about the Mainland China healthcare market and disease-specific trends.

Manufacturing 52

Manufacturing Marketing Leads Medicine 52

Clarivate

MAY 8, 2023

That was the overarching sentiment from the experienced group of biopharma leaders that formed the panel discussion chaired by Mike Ward, Clarivate Global Head of Life Sciences and Healthcare Thought Leadership, at this year’s AngloNordic Life Science conference. Timing is everything. billion for AstraZeneca in 2022.

Biopharma 52

Biopharma Sales Networking Pharma 52

PM360

OCTOBER 5, 2023

In total, PM360 , a leading life sciences marketing industry trade publication, recognized 73 winners across eight overall categories: Companies of the Year, CEOs of the Year, Products of the Year, Marketer of the Year, Marketing Team of the Year, Lifetime Achievement, Brand Champions, and Initiatives.

Education 52

Education Marketing Media Biopharma 52

eMediWrite

JUNE 6, 2022

The global pandemic has raised everyone’s awareness of the importance of healthcare. The global epidemic has raised everyone’s awareness of the importance of healthcare, and consumer expectations of businesses have shifted. Pre- and post-COVID-19, the volume of pharma press tripled. Introduction.

Pharmaceutical 52

Pharmaceutical Pharma Marketing Medicine 52

Pharmaceutical Technology

NOVEMBER 4, 2022

As visibility diminishes, mismanagement of the supply chain can not only lead to revenue and reputational damage for manufacturers but more importantly, loss of life for patients. The expertise in procurement for new projects is a definite advantage with choosing a CMO like Baxter BioPharma Solutions.

Biopharma 52

Biopharma Manufacturing Media Pharmaceutical 52

European Pharmaceutical Review

DECEMBER 19, 2022

1 However, as most biosimilars are developed by means of a complex biotechnological process in living organisms, this inevitably leads to differences between the biosimilar and the reference product. Marie Manley leads Sidley’s Life Sciences team in London and is a distinguished thought leader and adviser on EU and UK regulatory law.

Medicine 52

Medicine Biopharma Safety Food 52

Clarivate

OCTOBER 25, 2023

However, the ultimate impact of this program should have far-reaching effects for pharmaceutical companies and the broader healthcare system that bear monitoring as the IRA’s multi-year implementation schedule unfolds.

Prescription 52

Prescription Physicians Manufacturing Healthcare 52

Clarivate

OCTOBER 25, 2021

This year, Clarivate acquired Bioinfogate , a leading provider of analytics solutions in the life sciences and producer of the OFF-X portal. The move further expands and integrates drug toxicity data and translational safety intelligence from OFF-X into all aspects of the life science cycle.

Safety 110

Safety Biopharma Competition Management 110

PM360

NOVEMBER 12, 2023

Data clearly matters in pharma. The axiom ‘Most people use statistics like a drunk man uses a lamp post; more for support than illumination’ is especially applicable in today’s era of nearly unlimited data,” says David Marks, PhD, MSc, VP, Medical Director, Elevate Healthcare. billion by 2030, according to ReportLinker. “The

Marketing 59

Marketing Media Patients Healthcare 59

PM360

AUGUST 17, 2022

PM360 , a leading life sciences marketing industry trade publication, established the Trailblazer Awards in 2009 to recognize and honor outstanding companies, marketers, marketing teams, brand managers, and initiatives that have demonstrated innovation and achieved incredible results in the life sciences. SPECIALTY PHARMA/BIOTECH.

Marketing 52

Marketing Healthcare Healthcare Education 52

Clarivate

MARCH 14, 2024

Research is raising concerns about PFAS use Similarly, PFAS (per- and polyfluoroalkyl substances) in pharmaceutical packaging have recently come under scrutiny, leading to significant regulatory changes. With Europe taking the lead in introducing draft regulations on PFAS, will other countries and regions implement their own regulations?

Pharmaceutical 52

Pharmaceutical Manufacturing Food Healthcare Provider 52

PM360

SEPTEMBER 15, 2022

But battling information asymmetry is one of the best ways to address the ongoing inequities in our healthcare system. But to shift the industry’s approach to healthcare, all stakeholders must move the efforts, attention, and education necessary to find a common ground and ensure that the patients’ interests are always driving development.

Patients 98

Patients Healthcare Healthcare Marketing 98

PM360

AUGUST 9, 2022

Biopharma blockbusters in the last 10 years show a disturbing trend. As a top 10 biopharma company leader shared with us, “Real blockbusters are gone. Innovation Is Expanding, But Healthcare Systems Are Slow to Adapt. On average, they returned 11% less global revenue than previous years’ launches. In oncology, it’s 47% less.

Biopharma 69

Biopharma Marketing Healthcare Healthcare 69

PM360

JUNE 11, 2022

Only 5% of patients ranked pharma companies as the most trusted player in the healthcare space, according to a 2021 survey of 500 patients from Accenture. Patients want to know other patients are involved in what pharma is doing. Learn how pharma is involving them. They want to hear about those patients’ experiences.

Patients 59

Patients Pharma Education Media 59

European Pharmaceutical Review

FEBRUARY 21, 2023

Crucially, January 2023 marked a key moment: the Medicines and Healthcare products Regulatory Agency (MHRA) granted Celadon Pharmaceuticals the first good manufacturing practice (GMP) registration since legalisation in 2018 for high Δ9-tetrahydrocannabinol (THC) cannabis active pharmaceutical ingredient (API). He founded Celadon in 2018.

Medicine 127

Medicine Manufacturing Specialization Pharmaceutical 127

Silver Line CRM

SEPTEMBER 24, 2020

Through contracting with pharmaceutical and biotech companies, VMS BioMarketing provides clinical educator solutions focused on empowering healthcare providers and patients through product support, education, and training. Yet, VMS leads the clinical educator market in patient confidence to start and maintain therapy.

Education 52

Education Healthcare Healthcare CRM 52

Clarivate

NOVEMBER 13, 2023

Last year alone the Clarivate COA team conducted over 300 interviews with patients, caregivers or healthcare professionals. The work, said lead investigator Brett King, Associate Professor at Yale Dermatology, “helped change the landscape of alopecia areata forever.” Mainland China and Japan.

Patients 52

Patients Food and Drug Administration FDA Safety 52

Pharmaceutical Technology

JUNE 4, 2023

Encoded Therapeutics develops gene therapies for the treatment of severe genetic disorders.

Pharmaceutical 105

Pharmaceutical Leads Biopharma Engineering 105

Clarivate

DECEMBER 19, 2022

The plans are profitable and continue to draw new Medicare enrollees, leading all top payers to make investments in retaining and attracting enrollees. Teaming with Walmart allows UnitedHealth to keep its leading position in the Medicare Advantage segment, where it holds the top market share with 7.9 2 Humana by more than 2.5

Competition 52

Competition Retail Insurance Marketing 52

Clarivate

AUGUST 2, 2022

The CIRS study found that the FDA approved the highest number of NASs in 2021, continuing its streak of being the leading NAS approver since 2017. The UK Medicines and Healthcare Products Regulatory Agency (MHRA) joined the Access Consortium in January 2021 but did not approve any NASs in that year.

Medicine 98

Medicine Food and Drug Administration FDA Healthcare 98

PM360

SEPTEMBER 28, 2022

At Roche at the time, his job was to lead a task force which was given the objective of planning a strategy to preserve and protect the companies billion-dollar originator biologics franchises as well as build a plan which would counter the introduction and use of biosimilars. Now, as the President of Accord BioPharma , the U.S.

Competition 98

Competition Marketing Biopharma Manufacturing 98

European Pharmaceutical Review

APRIL 30, 2024

What are the top three trends that you are seeing in the biopharma manufacturing space? Let’s talk about continuous biopharma manufacturing. Speaking of your biopharma clients, what are you hearing about their main priorities? I believe this is going to be an emerging trend in the market.

Manufacturing 76

Manufacturing Food and Drug Administration Biopharma Marketing 76

Clarivate

NOVEMBER 10, 2022

The work, said lead investigator Brett King, Associate Professor at Yale Dermatology, “helped change the landscape of alopecia areata forever.”. Most importantly, newly approved treatments can address significant unmet needs for patients living with severe alopecia areata.

Patients 52

Patients Food and Drug Administration FDA Safety 52

Clarivate

MAY 13, 2024

Key takeaways Although growth in commercial and exchange enrollment will blunt some impacts, an increased uninsured rate will lead to increased uncompensated care, adding to cost pressures for health systems, especially safety-net hospitals that will see the highest volume of people cut from Medicaid. The post The U.S.

Insurance 52

Insurance Marketing Healthcare Healthcare 52